Harpoon Therapeutics Investor Relations Material
Latest events
Study Update
Harpoon Therapeutics
Corporate Presentation
1 Dec, 2023
Q3 2023
9 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Harpoon Therapeutics Inc
Access all reports
Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company engaged in the development of innovative T cell engagers. These engagers are designed to harness the power of the body's immune system to treat patients suffering from cancer and other diseases.The company is headquartered in South San Francisco, California, and its shares are listed on the Nasdaq.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
HARP
Country
🇺🇸 United States